[ad_1]
The United States will approve the second vaccine for emergency use
Golden Goat 2020-12-19
The number of confirmed cases of new crowns in the United States has recently risen, hospitals are overwhelmed, and wards for treating critically ill patients are full or nearly saturated.
The recent increase in confirmed cases of new crowns in many places in the United States has caused hospitals to be overwhelmed and wards for treating critically ill patients full or nearly full.
A committee of experts from the US Food and Drug Administration recommended on the 17th that the regulatory agency approve the second new corona vaccine for emergency use.
Room emergency
The United States is the most affected country in the world. The latest epidemic data from Johns Hopkins University in the United States shows that the United States has so far confirmed a total of almost 17.177 million cases and a total of more than 310,000 deaths.
The epidemic situation in California has been particularly dire in recent weeks. The intensive care units of many hospitals in the state are full or nearly saturated, prompting the re-implementation of “home ordering” in many places in California. Public health experts warn that when the intensive care unit is under severe pressure, the death rate of the new crown tends to rise.
Los Angeles’ intensive care unit is full. Mayor Eric Gachetti said on the 17th that more people are expected to die from the new crown.
A spokesman for “Arrow Regional Medical Center” in San Bernardino, Southern California, told Reuters that all the hospital’s intensive care units are full and that newly admitted patients can only be placed on temporary beds in the hallways. .
In Reno, western Nevada, a hospital converted a nearby parking lot into a 1,400-bed temporary medical facility. This medical center began accepting mild patients on November 12 to free the intensive care unit to receive critically ill patients.
Prepare the vaccine
The US Food and Drug Administration is studying the possibility of granting an emergency use authorization for the vaccine developed by Modena. A committee of external experts from the agency recommended on the 17th that the FDA approve the use of this vaccine.
This committee of experts determines the above opinions by vote. Experts agree that the benefits of this vaccine outweigh the disadvantages for people 18 years of age and older. FDA Director Stephen Hahn said on the 17th that the FDA will quickly complete the approval process.
In an interview with a Consumer News and Business Channel reporter on the 17th, US Secretary of Health and Human Services Alex Aza said 5.9 million doses of the Modena vaccine have been assigned to federal state governments and are ready for delivery and distribution. Ready.
On the 11th, the National Food and Drug Administration approved the emergency use authorization application for Pfizer Pharmaceuticals Co., Ltd. of the United States and the German Biotechnology Company to jointly develop the new corona vaccine. This vaccine is the first COVID-19 vaccine approved for emergency use in the United States for people 16 years of age and older.
The first batch of 2.9 million doses of vaccines jointly developed by Pfizer and New Biotechnology began shipping on the 13th and are being shipped to many hospitals and vaccination points one after another. Some older people and staff living in nursing homes have been vaccinated. The scope of vaccination will be extended to people who perform necessary jobs, the elderly and patients with chronic diseases.
However, some Americans and even medical personnel are ambivalent about receiving the new corona vaccine. Some people do not believe in the immunological effect of vaccines, and others believe that the speed of vaccine development is too fast.
Bao Xuelin (function of Xinhua News Agency)
Edit: quinn
